Changchun BCHT Biotechnology Co. (SHSE: 688276)
Health Care · Biotechnology · CN
CN¥17.36
+8.70% today · -31.5% 1Y
Changchun BCHT Biotechnology Co. (SHSE: 688276) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.07B and employs 1,252 people.
Over the last twelve months the share price has lost 31.5%, trading between 13.30 and 25.72.
Tweenvest scores Changchun BCHT Biotechnology Co. across four factors: quality 67/100, value 68/100, growth 0/100. Its strongest factor is value.
688276 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.07B
- Revenue (TTM)
- $91.96M
- P/E
- —
- EPS
- -0.59
- Dividend yield
- —
- Beta (5Y)
- 0.02
- 52-week high
- CN¥25.72
- 52-week low
- CN¥13.30
- Avg volume (3M)
- —
- Shares outstanding
- 413.66M
- Employees
- 1,252
- Next earnings
- —
About Changchun BCHT Biotechnology Co.
Changchun BCHT Biotechnology Co. Ltd. is a biopharmaceutical enterprise primarily focused on the research, development, production, and global commercialization of vaccines designed for human use. Its extensive product portfolio features key immunizations such as attenuated (live) herpes zoster and varicella vaccines, alongside a live, nasal, and freeze-dried influenza vaccine, and a rabies vaccine utilizing vero cell technology. This company was established in 2004 and is headquartered in Changchun, China.
- ISIN
- CNE100005XY6
- Founded
- 2004
- Listed since
- Jun 25, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.